⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALDX News
Aldeyra Therapeutics, Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Connect
accessnewswire.com
ALDX
Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ALDX
Form 8-K
sec.gov
ALDX
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors
businesswire.com
ALDX
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
businesswire.com
ALDX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Pomerantz LLP – ALDX
accessnewswire.com
ALDX
Pomerantz LLP Notifies Shareholders of Lawsuit Filed Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
businesswire.com
ALDX
ALDX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026
businesswire.com
ALDX
ALDX UPCOMING DEADLINE : The Gross Law Firm Alerts Aldeyra Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
globenewswire.com
ALDX